Clinical Trials | July 13, 2022
SRL Diagnostics launches fatty liver index
An algorithm based testing for Fatty Liver Disease
An algorithm based testing for Fatty Liver Disease
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
The drug helps in managing cholesterol
The DREAM-ND Phase III trial has now enrolled 588 CKD patients not-on-dialysis.
Subscribe To Our Newsletter & Stay Updated
